Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vigil Neuroscience, Inc.

2.02
-0.0900-4.27%
Post-market: 2.030.0100+0.50%19:32 EDT
Volume:78.36K
Turnover:162.86K
Market Cap:94.28M
PE:-0.98
High:2.18
Open:2.12
Low:2.02
Close:2.11
Loading ...

Company Profile

Company Name:
Vigil Neuroscience, Inc.
Exchange:
NASDAQ
Establishment Date:
2020
Employees:
66
Office Location:
100 Forge Road,Suite 700,Watertown,Watertown,Massachusetts,United States
Zip Code:
02472
Fax:
- -
Introduction:
Vigil Neuroscience, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain. Its lead candidate is VGL101(Iluzanebart), a human monoclonal antibody agonist targeting human triggering receptor expressed on myeloid cells 2 and is in a Phase 2 trial in patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), a rare and fatal neurodegenerative disease. The company is also developing VG-3927, an orally-available small molecule TREM2 agonist to treat common neurodegenerative diseases associated with microglial dysfunction, with an initial focus on Alzheimer's disease in genetically defined subpopulations, which is being evaluated in a Phase 1 clinical trial. It has license agreement with Amgen Inc. to commercially develop, manufacture, use, distribute, and sell therapeutic products containing compounds that bind to TREM2. The company was incorporated in 2020 and is headquartered in Watertown, Massachusetts.

Directors

Name
Position
Bruce Booth
Chairman of the Board
Ivana Magovcevic Liebisch
President, Chief Executive Officer and Director
Cheryl Renee Blanchard
Director
Clay B. Thorp
Director
Gerhard Koenig
Director
Shaan Gandhi
Director
Stefan Vitorovic
Director

Shareholders

Name
Position
Ivana Magovcevic Liebisch
President, Chief Executive Officer and Director
Evan A. Thackaberry
Senior Vice President, Head of Early Development
Jennifer Ziolkowski
Chief Financial Officer
Spyros Papapetropoulos
Chief Medical Officer